3 Citations (Scopus)

Abstract

Choosing appropriate antimicrobial therapy for prosthetic joint infections is a multifactorial and often complicated process. Factors that influence antimicrobial decision-making include pharmacodynamics, choice of surgical management, patient tolerance and allergy, financial considerations, and convenience of dosing. Recommendations regarding antimicrobial therapy for prosthetic joint infections vary greatly, and studies to define optimal therapy are lacking. Over the past 10 years, most of the literature on the treatment of prosthetic joint infection has focused on the utility of combination antimicrobial therapy and newer agents to combat multidrug-resistant pathogens.

Original languageEnglish (US)
Pages (from-to)529-532
Number of pages4
JournalCurrent Orthopaedic Practice
Volume23
Issue number6
DOIs
StatePublished - Nov 1 2012

Fingerprint

Arthroplasty
Joints
Pharmacology
Infection
Therapeutics
Decision Making
Hypersensitivity

Keywords

  • Antibiotic therapy
  • Hip arthroplasty
  • Knee arthroplasty
  • Prosthetic joint infection

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

The pharmacology of infection after total joint arthroplasty. / Hartman, Curtis W; Hewlett, Angela L; Garvin, Kevin Lloyd.

In: Current Orthopaedic Practice, Vol. 23, No. 6, 01.11.2012, p. 529-532.

Research output: Contribution to journalArticle

@article{72cf3444d98c4113b4e300454a25c943,
title = "The pharmacology of infection after total joint arthroplasty",
abstract = "Choosing appropriate antimicrobial therapy for prosthetic joint infections is a multifactorial and often complicated process. Factors that influence antimicrobial decision-making include pharmacodynamics, choice of surgical management, patient tolerance and allergy, financial considerations, and convenience of dosing. Recommendations regarding antimicrobial therapy for prosthetic joint infections vary greatly, and studies to define optimal therapy are lacking. Over the past 10 years, most of the literature on the treatment of prosthetic joint infection has focused on the utility of combination antimicrobial therapy and newer agents to combat multidrug-resistant pathogens.",
keywords = "Antibiotic therapy, Hip arthroplasty, Knee arthroplasty, Prosthetic joint infection",
author = "Hartman, {Curtis W} and Hewlett, {Angela L} and Garvin, {Kevin Lloyd}",
year = "2012",
month = "11",
day = "1",
doi = "10.1097/BCO.0b013e318271bfdc",
language = "English (US)",
volume = "23",
pages = "529--532",
journal = "Current Orthopaedic Practice",
issn = "1940-7041",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The pharmacology of infection after total joint arthroplasty

AU - Hartman, Curtis W

AU - Hewlett, Angela L

AU - Garvin, Kevin Lloyd

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Choosing appropriate antimicrobial therapy for prosthetic joint infections is a multifactorial and often complicated process. Factors that influence antimicrobial decision-making include pharmacodynamics, choice of surgical management, patient tolerance and allergy, financial considerations, and convenience of dosing. Recommendations regarding antimicrobial therapy for prosthetic joint infections vary greatly, and studies to define optimal therapy are lacking. Over the past 10 years, most of the literature on the treatment of prosthetic joint infection has focused on the utility of combination antimicrobial therapy and newer agents to combat multidrug-resistant pathogens.

AB - Choosing appropriate antimicrobial therapy for prosthetic joint infections is a multifactorial and often complicated process. Factors that influence antimicrobial decision-making include pharmacodynamics, choice of surgical management, patient tolerance and allergy, financial considerations, and convenience of dosing. Recommendations regarding antimicrobial therapy for prosthetic joint infections vary greatly, and studies to define optimal therapy are lacking. Over the past 10 years, most of the literature on the treatment of prosthetic joint infection has focused on the utility of combination antimicrobial therapy and newer agents to combat multidrug-resistant pathogens.

KW - Antibiotic therapy

KW - Hip arthroplasty

KW - Knee arthroplasty

KW - Prosthetic joint infection

UR - http://www.scopus.com/inward/record.url?scp=84872301703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872301703&partnerID=8YFLogxK

U2 - 10.1097/BCO.0b013e318271bfdc

DO - 10.1097/BCO.0b013e318271bfdc

M3 - Article

AN - SCOPUS:84872301703

VL - 23

SP - 529

EP - 532

JO - Current Orthopaedic Practice

JF - Current Orthopaedic Practice

SN - 1940-7041

IS - 6

ER -